Ultragenyx Pharmaceu (RARE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2014 | 06-2014 | 03-2014 | 12-2013 | 09-2013 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -43,064 | -27,215 | -13,630 | -35,070 | -23,753 |
| Depreciation Amortization | 2,916 | 1,674 | 596 | 1,850 | 1,304 |
| Accounts payable and accrued liabilities | 2,693 | 1,960 | 2,058 | 237 | 1,690 |
| Other Working Capital | 1,251 | -674 | -1,706 | -1,540 | -503 |
| Other Operating Activity | 4,024 | 3,105 | 2,061 | 3,323 | -165 |
| Operating Cash Flow | $-32,180 | $-21,150 | $-10,621 | $-31,200 | $-21,427 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -104,430 | -91,324 | -64,536 | -47,352 | -58,594 |
| PPE Investments | -1,696 | -1,257 | -569 | -400 | -278 |
| Other Investing Activity | -293 | -293 | -293 | 22 | 25 |
| Investing Cash Flow | $-106,419 | $-92,874 | $-65,398 | $-47,730 | $-58,847 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 188,905 | 128,395 | 128,385 | 171 | 133 |
| Dividend Paid | -4,346 | -4,346 | -4,346 | 0 | N/A |
| Other Financing Activity | 0 | 0 | 0 | -1 | 0 |
| Financing Cash Flow | $184,559 | $124,049 | $124,039 | $170 | $133 |
| Beginning Cash Position | 7,427 | 7,427 | 7,427 | 86,190 | 86,190 |
| End Cash Position | 53,387 | 17,452 | 55,447 | 7,420 | 6,049 |
| Net Cash Flow | $45,960 | $10,025 | $48,020 | $-78,760 | $-80,141 |
| Free Cash Flow | |||||
| Operating Cash Flow | -32,180 | -21,150 | -10,621 | -31,200 | -21,427 |
| Capital Expenditure | -1,696 | -1,257 | -569 | -407 | -278 |
| Free Cash Flow | -33,876 | -22,407 | -11,190 | -31,607 | -21,705 |